Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Annual account missing NBB
Fiscal year 2024 was expected before 31 July 2025 and has not been filed.
-
Busy address KBO
11 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2023
Association Pharmaceutique Belge-Algemene Pharmaceutische Bond from Brussel, company number BE0406753266, closed financial year 2023 with a result of € 1.6 million after tax. For that financial year Association Pharmaceutique Belge-Algemene Pharmaceutische Bond recorded revenue of € 12.4 million and equity of € 7.3 million. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 19, 2024.
€ 7.3 million
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 1.6 million
Profit after tax over the fiscal year.
€ 2 million
Cash and bank balances on the last day of the fiscal year.
People and assets in 2023
95.5
Average over the fiscal year, from the social balance sheet.
€ 8.9 million
€ 92,900 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 83,471
Book value of vehicles, furniture and equipment.
Debts at end 2023
None
No bank loans on the last day of the fiscal year.
€ 1.4 million
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 73 days on average.
€ 1.5 million
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
What happened to Association Pharmaceutique Belge-Algemene Pharmaceutische Bond?
What happened at Association Pharmaceutique Belge-Algemene Pharmaceutische Bond in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2023: profit of € 1.6 million. Source: NBB ↗
- Koen Straetmans stepped down as director. NBB
- Hendrik De Rocker stepped down as director. NBB
- Michael Storme stepped down as director. NBB
- Luc Adriaenssens stepped down as director. NBB
- Luc Vansnick stepped down as director. NBB
- Nicolas Echement stepped down as director. NBB
- Koen Straetmans became a director. NBB
In short
Paid € 59,255 in corporate taxes since 2023.
Pays suppliers within 73 days on average.
A new publication or filing at Association Pharmaceutique Belge-Algemene Pharmaceutische Bond? We notify you, reason included.
Follow Association Pharmaceutique Belge-Algemene Pharmaceutische BondDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
It owns 4% of Curalia Brokers BV/SRL itself.
Directors
According to the 2023 annual accounts
since 2021 · until 2024
Hendrik De Rocker
Director
Also active at: Belgisch Centrum voor Farmacotherapeutische Informatie-Centre Belge d'Information Pharmacothérapeutique, Ligue Cardiologique belge, S&H HOLDING
since 2021 · until 2024
since 2021 · until 2024
since 2021 · until 2024
Luc Vansnick
Director
since 2021 · until 2024
since 2021 · until 2024
Establishments
Establishment units
Physical locations of this company
Archimedesstraat 11
1000 Brussel
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 11 companies are registered at this address.
All companies at this address →La Nationale Pharmaceutique
Federation Nationale des Etudiants en Pharmacie
Societe Belge des Sciences Pharmaceutiques
Société belge des Pharmaciens spécialistes en Biologie clinique - Belgische Vereniging der Apothekers Specialisten in de Klinische Biologie
Institut Pharmaco - Epidémiologique Belge - Instituut Voor Farmaco - Epidemiologie van Belgie
+6 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0406.753.266
- VAT number
- BE 0406.753.266
- Registered office
- Archimedesstraat 11, 1000 Brussel
- Names & denominations
- Association Pharmaceutique Belge-Algemene Pharmaceutische Bond
- Enterprise type
- Rechtspersoon
- Legal form
- Non-profit association
- Legal situation
- Normale toestand
- Start date
- 30 December 1950
- Peppol
- Active · Active since 24 Jul 2025
- Activities · NACE
Activiteiten van bedrijfs- en werkgeversorganisaties
Bedrijfs- en werkgeversorganisaties
Activiteiten van beroepsorganisaties
Beroepsorganisaties
Uitgeven van tijdschriften
Uitgeverijen van tijdschriften